Articles by Lisel Viña - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Lisel Vi?a

Lisel Viña


CIMAvax-EGF quality control manager at the Centro de Inmunología Molecular (Center for Molecular Immunology)

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine
October 2, 2008

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.

ADVERTISEMENT

ADVERTISEMENT

Click here